Matches in SemOpenAlex for { <https://semopenalex.org/work/W1971872839> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W1971872839 abstract "Background Essential thrombocythaemia (ET) is an uncommon myeloproliferative disorder with an elevated platelet count. ET occurring in pregnancy has been reported to be mainly associated with first trimester abortion, preterm delivery, intrauterine growth retardation, placental abruption and preeclampsia. Purpose To describe the case of a pregnant patient diagnosed with essential thrombocythaemia who could not remain untreated due to complications of the disease. Materials and methods 35-year-old female patient diagnosed with essential thrombocythaemia untreated for months so she could try for a baby reached platelet counts of 1,118,000/mL. In the first month of pregnancy this could not be left untreated because complications can arise as such microthrombosis in blood vessels, leading to a high incidence of abortions in these patients. The treatment requested from pharmacy services for this case was interferon alpha-2 beta (IFN α-2b) which has shown no teratogenicity compared to other alternatives such as hydroxyurea or anagrelide. Low-dose acetylsalicylic acid is contraindicated in patients with platelet counts of more than a million/mL, due to the possibility of acquired Von Willebrand syndrome. Interferon alfa has not been approved for the indication of essential thrombocythaemia so its off-label use required approval by the hospital management. 3 MUI of IFN α-2b were administered twice weekly IV during gestation. Results Platelet counts decreased gradually from the beginning of treatment passing from 1,118,000/mL to 680,000/mL in two weeks, then 602,000/mL in the third month, in the fourth month 530,000/mL, 487,000/mL in the fifth month, in the sixth month 462,000/mL and in the seventh month 328,000/mL. During week 29 + 2 gave birth by emergency Caesarean section because of severe preeclampsia. Despite the complications, mother and child progressed favourably. Conclusions Essential thrombocythaemia is a difficult to treat disease in pregnancy. Sometimes you have to use drugs off-label. In this case, the IFN α-2b successfully reduced the platelet count during pregnancy. No conflict of interest." @default.
- W1971872839 created "2016-06-24" @default.
- W1971872839 creator A5019683919 @default.
- W1971872839 creator A5029135402 @default.
- W1971872839 creator A5033055030 @default.
- W1971872839 creator A5037382927 @default.
- W1971872839 creator A5044472014 @default.
- W1971872839 creator A5066012872 @default.
- W1971872839 date "2014-02-24" @default.
- W1971872839 modified "2023-10-17" @default.
- W1971872839 title "PS-086 Essential thrombocythaemia in pregnancy" @default.
- W1971872839 doi "https://doi.org/10.1136/ejhpharm-2013-000436.436" @default.
- W1971872839 hasPublicationYear "2014" @default.
- W1971872839 type Work @default.
- W1971872839 sameAs 1971872839 @default.
- W1971872839 citedByCount "0" @default.
- W1971872839 crossrefType "journal-article" @default.
- W1971872839 hasAuthorship W1971872839A5019683919 @default.
- W1971872839 hasAuthorship W1971872839A5029135402 @default.
- W1971872839 hasAuthorship W1971872839A5033055030 @default.
- W1971872839 hasAuthorship W1971872839A5037382927 @default.
- W1971872839 hasAuthorship W1971872839A5044472014 @default.
- W1971872839 hasAuthorship W1971872839A5066012872 @default.
- W1971872839 hasConcept C126322002 @default.
- W1971872839 hasConcept C131872663 @default.
- W1971872839 hasConcept C141071460 @default.
- W1971872839 hasConcept C187212893 @default.
- W1971872839 hasConcept C203014093 @default.
- W1971872839 hasConcept C2776106523 @default.
- W1971872839 hasConcept C2776178377 @default.
- W1971872839 hasConcept C2777218350 @default.
- W1971872839 hasConcept C2778642596 @default.
- W1971872839 hasConcept C2779225303 @default.
- W1971872839 hasConcept C2779234561 @default.
- W1971872839 hasConcept C2779788118 @default.
- W1971872839 hasConcept C2780829020 @default.
- W1971872839 hasConcept C2781057849 @default.
- W1971872839 hasConcept C2909179924 @default.
- W1971872839 hasConcept C29456083 @default.
- W1971872839 hasConcept C46973012 @default.
- W1971872839 hasConcept C54355233 @default.
- W1971872839 hasConcept C71924100 @default.
- W1971872839 hasConcept C86803240 @default.
- W1971872839 hasConcept C89560881 @default.
- W1971872839 hasConceptScore W1971872839C126322002 @default.
- W1971872839 hasConceptScore W1971872839C131872663 @default.
- W1971872839 hasConceptScore W1971872839C141071460 @default.
- W1971872839 hasConceptScore W1971872839C187212893 @default.
- W1971872839 hasConceptScore W1971872839C203014093 @default.
- W1971872839 hasConceptScore W1971872839C2776106523 @default.
- W1971872839 hasConceptScore W1971872839C2776178377 @default.
- W1971872839 hasConceptScore W1971872839C2777218350 @default.
- W1971872839 hasConceptScore W1971872839C2778642596 @default.
- W1971872839 hasConceptScore W1971872839C2779225303 @default.
- W1971872839 hasConceptScore W1971872839C2779234561 @default.
- W1971872839 hasConceptScore W1971872839C2779788118 @default.
- W1971872839 hasConceptScore W1971872839C2780829020 @default.
- W1971872839 hasConceptScore W1971872839C2781057849 @default.
- W1971872839 hasConceptScore W1971872839C2909179924 @default.
- W1971872839 hasConceptScore W1971872839C29456083 @default.
- W1971872839 hasConceptScore W1971872839C46973012 @default.
- W1971872839 hasConceptScore W1971872839C54355233 @default.
- W1971872839 hasConceptScore W1971872839C71924100 @default.
- W1971872839 hasConceptScore W1971872839C86803240 @default.
- W1971872839 hasConceptScore W1971872839C89560881 @default.
- W1971872839 hasLocation W19718728391 @default.
- W1971872839 hasOpenAccess W1971872839 @default.
- W1971872839 hasPrimaryLocation W19718728391 @default.
- W1971872839 isParatext "false" @default.
- W1971872839 isRetracted "false" @default.
- W1971872839 magId "1971872839" @default.
- W1971872839 workType "article" @default.